Changes in the Gut Microbial Diversity and Its Correlation with the Clinical Outcome in Children with Acute Myeloid Leukemia (AML) Receiving Induction Chemotherapy

被引:1
|
作者
Adel, Mai [1 ]
Khedr, Reham Abdelaziz [1 ,2 ]
Elsayed, Ahmed [3 ]
Shalaby, Lobna [4 ]
Omar, Abdelrahman [5 ]
Diab, Aya A. [6 ]
Elanany, Mervat [7 ]
Lehmann, Leslie E. [8 ]
Elhaddad, Alaa [9 ]
机构
[1] Childrens Canc Hosp Egypt, Pediat Oncol, Cairo 57357, Egypt
[2] Cairo Univ, Natl Canc Inst, Pediat Oncol, Cairo, Egypt
[3] Childrens Canc Hosp Egypt, Basic Res Genom Lab, Cairo 57357, Egypt
[4] Cairo Univ, Cairo, Egypt
[5] Childrens Canc Hosp Egypt, Cairo, Egypt
[6] Childrens Canc Hosp EGYPT, Basic Res LAb, Cairo, Egypt
[7] Children Canc Hosp Egypt, Clin Pathol, Cairo 57357, Egypt
[8] Dana Farber Boston Childrens Canc & Blood Disorde, Div Pediat Hematol Oncol, Stem Cell Transplant Program, Boston, MA USA
[9] Childrens Canc Hosp Egypt, Pediat Oncol & BMT, Cairo 57357, Egypt
关键词
D O I
10.1182/blood-2022-158654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:11769 / 11770
页数:2
相关论文
共 50 条
  • [21] Immune Modulation with Pomalidomide after Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
    Montiel-Esparza, Raul
    Knaus, Hanna A.
    Zeidner, Joshua F.
    Vulic, Ante
    Prince, Gabrielle T.
    Smith, B. Douglas
    Levis, Mark J.
    Streicher, Howard
    Karp, Judith E.
    Luznik, Leo
    Gojo, Ivana
    BLOOD, 2015, 126 (23)
  • [22] Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re-induction chemotherapy
    Ruan, Min
    Liu, Li-Peng
    Zhang, Ao-Li
    Quan Qi, Ben
    Liu, Fang
    Liu, Tian-Feng
    Liu, Xiao-Ming
    Chen, Xiao-Juan
    Yang, Wen-Yu
    Guo, Ye
    Zhang, Li
    Zou, Yao
    Chen, Yu-Mei
    Zhu, Xiao-Fan
    CANCER MEDICINE, 2021, 10 (03): : 956 - 964
  • [23] Mutational Profile and Clinical Outcome in RUNX1-Mutated Acute Myeloid Leukemia, Not Otherwise Specified (AML, NOS) and Acute Myeloid Leukemia with Myelodysplastic-Related Changes (AML-MRC)
    Nguyen, Lynh
    Zhang, Ling
    Zhang, Xiaohui
    Song, Jinming
    Braswell, Diana S.
    MODERN PATHOLOGY, 2018, 31 : 541 - 541
  • [24] Mutational Profile and Clinical Outcome in RUNX1-Mutated Acute Myeloid Leukemia, Not Otherwise Specified (AML, NOS) and Acute Myeloid Leukemia with Myelodysplastic-Related Changes (AML-MRC)
    Lynh Nguyen
    Zhang, Ling
    Zhang, Xiaohui
    Song, Jinming
    Braswell, Diana S.
    LABORATORY INVESTIGATION, 2018, 98 : 541 - 541
  • [25] Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome
    Alhajahjeh, Abdulrahman
    Bewersdorf, Jan Philipp
    Bystrom, Rebecca P.
    Zeidan, Amer M.
    Shimony, Shai
    Stahl, Maximilian
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1541 - 1551
  • [26] Clinical Impact of CD200 Expression on Outcome of Acute Myeloid Leukemia (AML)
    Girshova, Larisa
    Shatilova, Aleksina
    Budaeva, Irina
    Matvienko, Yulia
    Levchuk, Ksenia
    Mirolubova, Julia
    Alexeeva, Julia
    Lomaia, Elza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S294 - S295
  • [27] Clinical Relevance of Partial Response in the Marrow (PRm) after Failure of Frontline Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML)
    Fleming, Shaun
    Ong, Doen Ming
    Jackson, Kathryn
    Avery, Sharon
    Mollee, Peter
    Marlton, Paula
    Kennedy, Glen A.
    Wei, Andrew
    BLOOD, 2015, 126 (23)
  • [28] Correlation of Serum Oxidative Stress with the Effect of Initial Induction Chemotherapy in Acute Myeloid Leukemia
    Xie, Shanshan
    Xiao, Ting
    Wang, Wentian
    Guo, Xiaoru
    CLINICAL LABORATORY, 2024, 70 (11) : 2071 - 2080
  • [29] Validation of AML-score in Older Adults Receiving CPX-351 Intensive Induction Chemotherapy for Treatment of Secondary Acute Myeloid Leukemia
    Schmucker, Abigail M.
    Leiby, Benjamin E.
    Wilde, Lindsay
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : E206 - E212
  • [30] Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
    Versluis, Jurjen
    Flamand, Yael
    Haydu, Erika J.
    Vedula, Rahul S.
    Charles, Anne
    Copson, Kevin
    Wolach, Ofir
    Bendapudi, Pavan
    Belizaire, Roger
    Neuberg, Donna S.
    Luskin, Marlise R.
    Lindsley, R. Coleman
    BLOOD, 2020, 136